TIPE2 Associated With Kidney Transplant

This study has suspended participant recruitment.
Sponsor:
Information provided by:
Xi’an Jiaotong University College of Medicine
ClinicalTrials.gov Identifier:
NCT01059292
First received: January 28, 2010
Last updated: NA
Last verified: October 2009
History: No changes posted
  Purpose

TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. The investigators want to know whether TIPE2 is a risk factor for graft loss and gives rise to the immune dysfunction in renal transplant patients.


Condition
Renal Transplant

Study Type: Observational
Official Title: Department of Renal Transplantation, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China

Resource links provided by NLM:


Further study details as provided by Xi’an Jiaotong University College of Medicine:

Estimated Enrollment: 93
Study Start Date: October 2009
  Eligibility

Ages Eligible for Study:   20 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

kidney transplant patients and healty Volunteers

Criteria

Inclusion Criteria:

  • long-term surival(>5year),AR and CR kidney transplant patients and healty Volunteers as control

Exclusion Criteria:

  • without hepatitis , tumor and infections
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Department of Renal Transplantation, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University
ClinicalTrials.gov Identifier: NCT01059292     History of Changes
Other Study ID Numbers: jia123456
Study First Received: January 28, 2010
Last Updated: January 28, 2010
Health Authority: China: Ethics Committee

Keywords provided by Xi’an Jiaotong University College of Medicine:
we have complieted party research

ClinicalTrials.gov processed this record on July 23, 2014